PN 78143
RN 00923 
AN 78091015
AU Sparham-P-D.  Lobban-D-I.  Speller-D-C.
TI Thymidine-requiring Staphylococcus aureus [letter].
SO Lancet. 1978 Jan 14. 1(8055). P 104-5.
MJ STAPHYLOCOCCUS-AUREUS: gd.  THYMIDINE.
MN CYSTIC-FIBROSIS: mi.  DRUG-RESISTANCE-MICROBIAL.  HUMAN.
   TRIMETHOPRIM: ad.
EX We confirm that thymidine-requiring (thy-) Staphylococcus aureus
   strains are common in patients with cystic fibrosis.  In 7 months, we
   isolated Staph. aureus from 11 of 14 patients with C.F.  Despite
   long-term co-trimoxazole Staph. aureus tends to persist in the sputum
   even though isolates do not require thymidine at first and are
   trimethoprim-sensitive in vitro.  Staph. aureus is less commonly
   isolated, and of less significance, in most other chest conditions
   for which co-trimoxazole is given.  These factors may explain why
   thy- staphylococci are recognised more frequently in C.F. than in
   other diseases.
RF 000   GEORGE RH             LANCET                           2  1081 977
   002   WILLIAMS RF           PROC EWGCF 6TH ANNU MTG                4 975
CT   1   WILLIAMS RF           CURR MED RES OPIN                6    43 979
     2   STURM AW              ANT V LEEUW J MICROBIOL SEROL   47    92 981
     3   LACEY RW              J MED MICROBIOL                 15   403 982
     4   KING CH               J CLIN MICROBIOL                18    79 983